Analysts at JMP Securities upgraded Infinity Pharmaceuticals INFI from Market Perform to Market Outperform.
The target price for Infinity Pharmaceuticals is set to $24.
Infinity Pharmaceuticals shares have dropped 22.09% over the past 52 weeks, while the S&P 500 index has gained 20.88% in the same period.
Infinity Pharmaceuticals' shares jumped 44.05% to close at $15.73 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in